Christian Brothers Investment Services, Inc. (CBIS) and 13 other faith-based institutional investors with approximately $35 million in Abbott Laboratories holdings responded today to the pharmaceutical company's decision to withdraw new drug applications from Thailand with a request that Abbott immediately reverse its decision...In a joint statement, CBIS and the other faith-based investors said: “...To our knowledge, no pharmaceutical company has before withdrawn AIDS drugs in response to a pricing or licensing dispute. By keeping life-saving medicines like Kaletra off the shelves in Thailand, Abbott Labs is threatening the health of Thais who need access to these drugs...We are concerned that Abbott’s actions...have the potential to damage its reputation and impact the bottom-line...”